Twist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Conference Call November 18, 2024 8:00 AM ET
Company Participants
Angela Bitting - SVP, Corporate Affairs
Emily Leproust - CEO and Co-Founder
Adam Laponis - CFO
Patrick Finn - President and COO
Conference Call Participants
Matt Sykes - Goldman Sachs
Vijay Kumar - Evercore ISI
Sung-Ji Nam - Scotiabank
Subbu Nambi - Guggenheim Securities
Luke Sergott - Barclays
Matt Larew - William Blair
Puneet Souda - Leerink Partners
Tom Peterson - Baird
Chad Wiatrowski - TD Cowen
Thomas DeBourcy - Nephron Research
Rachel Vatnsdal - JPMorgan
Operator
Welcome to Twist Bioscience's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to turn the conference over to Angela Bitting, SVP of Corporate Affairs.
Angela Bitting
Thank you, operator. Good morning, everyone. I would like to thank you for joining us for Twist Bioscience's conference call to review our fiscal 2024 fourth quarter financial results and business progress. We issued our financial results press release before market and it is available at our website at www.twistbioscience.com. With me on the call today are Dr. Emily Leproust, CEO and Co-Founder of Twist; Adam Laponis, CFO of Twist; and Dr. Patrick Finn, President and COO of Twist.
Today we will discuss our business progress, financial and operational performance, as well as growth opportunities. We will then open up the call for questions. We ask that you limit your questions to only one and then re-queue as a courtesy to others on the call. This call is being recorded and the audio portion will be archived in the Investors section of our website and will be available for two weeks.
During today's presentation, we will make forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize, and actual results and financial periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include those set forth in the press release we issued earlier today as well as those more fully described in our filings with the SEC.
The forward-looking statements in this presentation are based on the information available to us as of the date hereof, and we disclaim any obligation to update any forward-looking statements except as required by law. We'll also discuss adjusted EBITDA, as financial measure that does not conform with the Generally Accepted Accounting principles.